bioRxivNeurosciencePreprint
Chiral shift toward D-serine reflects intrathecal inflammation in multiple sclerosis and counteracts motor impairment in a murine model
Alessandro UsielloiD, Kenta Arisumi, Tommaso NuzzoiD, Luana GilioiD, Sakiko Taniguchi, Rosita RussoiD, Haruhiko MotegiiD, Raffaella di VitoiD, Junichi HataiD, Francesco ErricoiD, Akinori HashiguchiiD, Hideyuki OkanoiD, Roberto FurlaniD, Annamaria FinardiiD, Mario Stampanoni BassiiD, Jin NakaharaiD, Masashi MitaiD, Takanori Kanai∥iD, Angela ChamberyiD, Masato YasuiiD, Diego CentonzeiD, Jumpei SasabeiD
Abstract
Multiple sclerosis (MS) is characterized by chronic inflammatory demyelination involving complex interplay between the central nervous and immune systems. Neuroinflammation triggers cellular reorganization requiring O_SCPLOWLC_SCPLOW-serine for sustained syntheses of membrane lipids and nucleic acids, whereas it causes aberrant glutamatergic neurotransmission involving O_SCPLOWDC_SCPLOW-serine. However, significance of serine metabolism in MS pathology remains unexplored. Here we show that serine chiral homeostasis is disrupted in MS and endogenous O_SCPLOWDC_SCPLOW-serine prevents motor deficits caused by inflammatory demyelination. We found in a large cohort study that patients with MS exhibit elevated O_SCPLOWDC_SCPLOW-serine levels and the O_SCPLOWDC_SCPLOW-/total serine ratio in the cerebrospinal fluid at diagnosis. Steric deviation toward O_SCPLOWDC_SCPLOW-serine accords with emergence of the intrathecal inflammatory marker oligoclonal bands, and correlates negatively with proinflammatory cytokines. An in vivo animal model of MS, genetically engineered to exhibit distinct metabolic states of O_SCPLOWDC_SCPLOW-serine, revealed that endogenous O_SCPLOWDC_SCPLOW-serine synthesis mitigates the progression of motor deficits and suppresses proinflammatory and vascular endothelial pathogenic signaling. Moreover, pre-symptomatic oral supplementation with O_SCPLOWDC_SCPLOW-serine, but not O_SCPLOWLC_SCPLOW-serine, enhances production of extracellular matrices, preserves integrity of the blood brain barrier, attenuates demyelination, and improves motor function. Contrary to the previously recognized neurotoxic nature of O_SCPLOWDC_SCPLOW-serine, our findings reveal an unrecognized significance of O_SCPLOWDC_SCPLOW-serine metabolism in MS and a protective function of O_SCPLOWDC_SCPLOW-serine against neuroinflammation involving disruption of the blood brain barrier, which may present an untapped therapeutic target in MS. One Sentence SummarySerine chiral homeostasis is disturbed in multiple sclerosis and O_SCPLOWDC_SCPLOW-serine mitigates inflammatory demyelination.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Carnosine synthase deficiency aggravates neuroinflammation in multiple sclerosis
Jan Spaas, Thibaux Van der Stede, … Wim Derave·Progress in NeurobiologyPeer-reviewed·Sep 27, 2023
- Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation
Pavan Bhargava, Matthew D. Smith, … Peter A. Calabresi·Journal of Clinical InvestigationPeer-reviewed·Mar 17, 2020
- ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: a human and experimental study
Jonathan D. Zurawski, Alara Tuncer, … Chao Wang·Proceedings of the National Academy of SciencesPeer-reviewed·Mar 13, 2026
- Multiple sclerosis: Effects of fixed-dose combination of dimethyl fumarate and NADPH oxidase inhibitor on oxidative stress markers and neurobehavioral activity in mice model of cuprizone-induced demyelination
K. Dhananjayan, G. Mani·bioRxiv·Dec 10, 2023
- Mouse model of multiple sclerosis induced by disrupting vesicular transport in oligodendrocytes
Chun Hin Chow, Mengjia Huang, … Shuzo Sugita·bioRxiv·Aug 24, 2023
- Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types
Insha Zahoor, Mohammad Nematullah, … Shailendra Giri·bioRxiv·Sep 25, 2023